Fig. 1.
Fig. 1. PKC in erythrocytes. (A) Translocation of PKC activity from cytosol to membrane in uninfected erythrocytes exposed to DMSO (□) or 500 nmol/L PMA (▨) for 15 minutes. PKC activity given is the total kinase activity minus activity measured in the absence of lipid activators (PMA/phosphatidyl-serine/Triton-X–100 mixed micelles) and the presence of 20 μmol/L PKC.19-36 Activities represent the mean of duplicate assays + range. This result is representative of six separate experiments. (B) Western blot of whole cell lysates from uninfected cells, prepared and separated on a 10% acrylamide gel (107 cell equivalents/lane) as described in Materials and Methods. Blots were incubated with monoclonal antibodies as follows: lane 1, anti-PKCα at 0.05 μg/mL; lane 2, anti-PKCβ at 0.16 μg/mL; lane 3, anti-PKCγ at 0.25 μg/mL; lane 4, anti-PKCε at 0.5 μg/mL; lane 5, anti-PKCθ at 1 μg/mL; lane 6, anti-PKC ι at 1.6 μg/mL and lane 7, anti-PKCλ at 1.6 μg/mL. No bands were detected in parallel blots incubated with control antibodies or second layer only (not shown).

PKC in erythrocytes. (A) Translocation of PKC activity from cytosol to membrane in uninfected erythrocytes exposed to DMSO (□) or 500 nmol/L PMA (▨) for 15 minutes. PKC activity given is the total kinase activity minus activity measured in the absence of lipid activators (PMA/phosphatidyl-serine/Triton-X–100 mixed micelles) and the presence of 20 μmol/L PKC.19-36 Activities represent the mean of duplicate assays + range. This result is representative of six separate experiments. (B) Western blot of whole cell lysates from uninfected cells, prepared and separated on a 10% acrylamide gel (107 cell equivalents/lane) as described in Materials and Methods. Blots were incubated with monoclonal antibodies as follows: lane 1, anti-PKCα at 0.05 μg/mL; lane 2, anti-PKCβ at 0.16 μg/mL; lane 3, anti-PKCγ at 0.25 μg/mL; lane 4, anti-PKCε at 0.5 μg/mL; lane 5, anti-PKCθ at 1 μg/mL; lane 6, anti-PKC ι at 1.6 μg/mL and lane 7, anti-PKCλ at 1.6 μg/mL. No bands were detected in parallel blots incubated with control antibodies or second layer only (not shown).

Close Modal

or Create an Account

Close Modal
Close Modal